Schedule Dispatches
Schedule dispatches give a summary of changes coming out in the next month.
This is an early notification of the changes to be announced in the Update to the Pharmaceutical Schedule.
The full Update is available as a PDF(external link)
The changes will be published in the online Schedule around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz
April 2025
Changes to pack size descriptions update
New Listings
- Acetazolamide (Medsurge) tab 250 mg (p’code 2670801)
- Acetylcysteine (Hikma Acetylcysteine) inj 200 mg per ml, 10 ml vial – section 29 and wastage claimable (p’code 2701928)
- Aminoacid formula without phenylalanine liquid (berry (p’code 2702010) and orange (p’code 2702029)), 125 ml bottle, 1 OP (PKU Anamix Junior LQ) and powder (neutral), 4 x 400 g can, 1,600 g OP (PKU Start) (p’code 2702037) – Special Authority – Hospital pharmacy [HP3]
- Axitinib (Inlyta) tab 1 mg (p’code 2432692) and 5 mg (p’code 2432706) – Special Authority – Retail pharmacy and wastage claimable
- Carmellose sodium with gelatin and pectin (Stomahesive) paste, 56.7 g OP (p’code 2703203)
- Cetomacrogol with glycerol (Evara) crm 90% with glycerol 10%, 460 g OP (p’code 2702886) and 920 g OP (p’code 2702894)
- Compound electrolytes with glucose [dextrose] (Hydralyte – Lemonade) soln with electrolytes, 1 OP (p’code 2702908)
- Crizotinib (Xalkori) cap 200 mg (p’code 2467593) and 250 mg (p’code 2467607) – Special Authority – Retail pharmacy
- Desmopressin acetate (Desmopressin-PH&T) nasal spray 10 mcg per dose, 6 ml, 60 OP (p’code 2702916)
- Desogestrel (Cerazette) tab 75 mcg – Up to 84 tab available on a PSO (p’code 2261286)
- Diabetic enteral feed 1kcal/ml (Glucerna Select) liquid, 500 ml bottle, 1 OP - Special Authority – Hospital pharmacy [HP3] (p’code 2702037)
- Diabetic oral feed 1kcal/ml liquid (strawberry), 200 ml bottle, 1 OP (Diasip) (p’code 2702053) and liquid (vanilla), 200 ml bottle, 1 OP (Nutren Diabetes (p’code 2702088) and Diasip (p’code 2702061) – Special Authority - Hospital pharmacy [HP3]
- Dimethicone crm 5% pump bottle, 460 g OP (healthE Dimethicone 5%) (p’code 2702924) and crm 10% pump bottle, 460 g OP (healthE Dimethicone 10%) (p’code 2702932)
- Enteral feed 1kcal/ml liquid, 250 ml bottle, 1 OP (Isosource Standard) (p’code 2702096) and liquid, 1,000 ml bottle, 1 OP (Osmolite RTH (p’code 2702126) and Nutrison RTH) (p’code 2702118) – Special Authority - Hospital pharmacy [HP3]
- Enteral feed 1.5kcal/ml liquid, 250 ml can, 1 OP (Ensure Plus HN) (p’code 2702339) and liquid, 1,000 ml bottle, 1 OP (Ensure Plus HN RTH (p’code 2702347) and Nutrison Energy (p’code 2702355)) – Special Authority - Hospital pharmacy [HP3]
- Enteral feed 2 kcal/ml liquid, 500 ml bottle, 1 OP (Nutrison Concentrated) (p’code 27022371) and liquid, 1,000 ml bottle,1 OP (Ensure Two Cal HN RTH) (p’code 2702363) – Special Authority - Hospital pharmacy [HP3]
- Enteral feed with fibre 0.83 kcal/ml (Nutrison 800 Complete Multi Fibre) liquid, 1,000 ml bottle, 1 OP – Special Authority – Hospital pharmacy [HP3] (p’code 2702398)
- Enteral feed with fibre 1 kcal/ml (Jevity RTH (p’code 2702401) and Nutrison Multi Fibre (p’code 2702428)) liquid, 1,000 ml bottle, 1 OP – Special Authority – Hospital pharmacy [HP3]
- Enteral feed with fibre 1.2kcal/ml (Jevity Plus RTH) liquid, 1,000 ml bottle, 1 OP - Special Authority – Hospital pharmacy [HP3] (p’code 2702436)
- Enteral feed with fibre 1.5kcal/ml (Jevity HiCal RTH (p’code 2702444) and Nutrison Energy Multi Fibre (p’code 2702452)) liquid, 1,000 ml bottle, 1 OP – Special Authority – Hospital pharmacy [HP3]
- Enteral liquid peptide formula liquid 1 kcal/ml, 500 ml bottle, 1 OP (Nutrini Peptisorb) (p’code 2702460) and liquid 1.5 kcal/ml, 500 ml bottle, 1 OP (Nutrini Peptisorb Energy) (p’code 2702479) - Special Authority – Hospital pharmacy [HP3]
- Enteral/oral semi-elemental feed 1.5kcal/ml (Vital) liquid, 1,000 ml bottle, 1 OP - Special Authority – Hospital pharmacy [HP3] (p’code 2702487)
- Oral feed 1.5kcal/ml liquid (banana (p’code 2702509), chocolate (p’code 2702525), fruit of the forest (p’code 2702541) and vanilla (p’code 2702576), 200 ml bottle, 1 OP (Ensure Plus), liquid (vanilla), 237 ml can, 1 OP (Ensure Plus) (p’code 2702584) and liquid (banana (p’code 2702517), chocolate (p’code 2702533), strawberry (p’code 2702568) and vanilla (p’code 2702592), 200 ml bottle, 1 OP (Fortisip) – Special Authority – Hospital pharmacy [HP3] and additional subsidy by endorsement
- Inotuzumab ozogamicin inj 1 mg vial (Besponsa) (p’code 2598981) and inj 1 mg for ECP (Baxter) (p’code 2701790) – PCT only – Specialist – Special Authority
- Insulin isophane (Humulin NPH (p’code 2702940) and Protaphane (p’code 2702959) inj human 100 u per ml, 10 ml vial, 1 OP
- Insulin isophane with insulin neutral (Humulin 30/70 (p’code 2702975) and Mixtard 30 (p’code 2702967) inj human with neutral insulin 100 u per ml, 10 ml vial, 1 OP
- Insulin lispro (Humalog) inj 100 u per ml, 10 ml vial, 1 OP (p’code 2702983)
- Insulin neutral (Actrapid (p’code 2702991) and Humulin R (p’code 2703009)) inj human 100 u per ml, 10 ml vial, 1 OP
- Insulin pump cartridge (Tandem Cartridge) cartridge 300 U, t:lock × 10, 10 OP - Special Authority – Retail pharmacy, maximum of 50 cartridges per prescription, only on a prescription and maximum of 190 cartridges will be funded per year (p’code 2703017)
- Insulin pump reservoir 10 × 1.6 ml glass reservoir for YpsoPump, 10 OP (mylife YpsoPump Reservoir) (p’code 2703025), 10 × luer lock conversion cartridges 1.8 ml for Paradigm pumps, 10 OP (ADR Cartridge 1.8) (p’code 2703033) and cartridge for 7 series pump; 3.0 ml × 10, 10 OP (MiniMed 3.0 Reservoir MMT-332A) (p’code 2703041) – Special Authority – Retail pharmacy, maximum of 90 cartridges per prescription, only on a prescription and maximum of 360 cartridges will be funded per year
- Ipilimumab inj 5 mg per ml, 10 ml (p’code 2703238) and 40 ml vial (p’code 2703246) (Yervoy) and inj 1 mg for ECP (Baxter) (p’code 2701782) – PCT only – Specialist – Special Authority
- Lanreotide (Mytolac) inj 90 mg per 0.5 ml, 0.5 ml syringe – Special Authority - Retail pharmacy (p’code 2698153)
- Levonorgestrel (Jadelle) subdermal implant (2 × 75 mg rods), 2 OP – Up to 3 implants available on a PSO (p’code 2703068)
- Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride (APO Health Macrogol) powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg – S29 and wastage claimable (p’code 2703106)
- Oral elemental feed 1kcal/ml (Vivonex TEN) powder (unflavoured), 80 g sachet, 1 OP – Special Authority – Hospital pharmacy [HP3] (p’code 2702495)
- Oral feed 2 kcal/ml (Two Cal HN) liquid (vanilla), 200 ml bottle, 1 OP - Special Authority – Hospital pharmacy [HP3] and additional subsidy by endorsement (p’code 2702606)
- Oral feed with fibre 1.5 kcal/ml (Fortisip Multi Fibre) liquid (chocolate (p’code 2702614), strawberry (p’code 2702622) and vanilla (p’code 2702630), 200 ml bottle, 1 OP – Special Authority – Hospital pharmacy [HP3] and additional subsidy by endorsement
- Paediatric enteral feed 1kcal/ml (Pediasure RTH (p’code 2702673) and Nutrini RTH p’code 2702665)) liquid, 500 ml bottle, 1 OP – Special Authority – Hospital pharmacy [HP3]
- Paediatric enteral feed 1.5kcal/ml (Nutrini Energy RTH) liquid, 500 ml bottle, 1 OP - Special Authority – Hospital pharmacy [HP3] (p’code 2702649)
- Paediatric enteral feed with fibre 0.76 kcal/ml (Nutrini Low Energy Multi Fibre) liquid, 500 ml bottle, 1 OP – Special Authority – Hospital pharmacy [HP3] (p’code 2702681)
- Paediatric enteral feed with fibre 1.5kcal/ml (Nutrini Energy Multi Fibre) liquid, 500 ml bottle, 1 OP – Special Authority – Hospital pharmacy [HP3] (p’code 2702703)
- Paediatric oral feed 1kcal/ml (Pediasure) liquid (chocolate (p’code 2702746), strawberry (p’code 2702762) and vanilla (p’code 2702770), 200 ml bottle, 1 OP and liquid (vanilla), 250 ml can, 1 OP (p’code 2702797) – Special Authority - Hospital pharmacy [HP3]
- Paediatric oral feed 1.5kcal/ml liquid (strawberry (p’code 2702711) and vanilla (p’code 2702738), 200 ml bottle, 1 OP (Fortini) and liquid (vanilla), 500 ml bottle, 1 OP (Pediasure Plus) (p’code 2702746) – Special Authority – Hospital pharmacy [HP3]
- Paediatric oral feed with fibre 1.5kcal/ml (Fortini Multi Fibre) liquid (unflavoured (p’code 2702819), chocolate (p’code 2701797), strawberry (p’code 2702800) and vanilla (p’code 2702827), 200 ml bottle, 1 OP – Special Authority - Hospital pharmacy [HP3]
- Paediatric oral/enteral feed 1 kcal/ml (Infatrini) liquid, 125 ml bottle, 1 OP - Special Authority – Hospital pharmacy [HP3] (p’code 2702835)
- Pharmacy services (BSF Teriflunomide Sandoz) brand switch fee – may only be claimed once per patient (p’code 2701847)
- Quetiapine (Quetiapine Viatris) tab 25 mg, 30 tab (p’code 2701162) and 500 tab (2701170) – safety medicine, wastage claimable
- Renal oral feed 1.8 kcal/ml (Nepro HP (strawberry (p’code 2702843) and vanilla (p’code 2702851)) liquid, 220 ml carton, 1 OP – Special Authority – Hospital pharmacy [HP3]
- Ribociclib (Kisqali) tab 200 mg, 21 tab (p’code 2701340), 42 tab (p’code 2701359) and 63 tab (p’code 2701367) – Special Authority - Retail pharmacy, wastage claimable
- Rotavirus oral vaccine (Rotarix) oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, squeezable tube (PVC free) – only on a prescription, no patient co-payment payable and access criteria apply (p’code 2679558)
- Semi-elemental enteral feed 1kcal/ml (Nutrison Advanced Peptisorb) liquid, 500 ml bottle, 1 OP – Special Authority – Hospital pharmacy [HP3] (p’code 2702878)
- Sodium chloride (Baxter) inj 0.9%, bag, 500 ml – up to 4 bags available on a PSO (p’code 2703076) and inj 0.9%, bag, 1,000 ml bag – up to 2 bags available on a PSO (p’code 2703084)
- Varenicline tartrate (Champix) tab 0.5 mg × 11 and 1 mg × 42, 53 OP (p’code 2609363) and tab 1 mg (p’code 2251604) – Special Authority – Retail pharmacy, maximum of 12 weeks’ varenicline subsidised on each Special Authority approval, will not be funded in amounts less than 4 weeks of treatment, and the 6-month time period in which a patient can receive a funded 12-week course of varenicline tartrate starts from the date the Special Authority is approved
- Testosterone (Testogel) gel (transdermal) 16.2 mg per g, 88 g, 60 OP (p’code 2703092)
- Zoledronic acid (Zoledronic Acid Viatris) inj 0.05 mg per ml, 100 ml, bag (p’code 2703106)
Changes to restrictions, chemical names and presentations
- Atorvastatin tab 10 mg, 20 mg, 40 mg and 80 mg (Lorstat) and tab 20 mg (Lipitor) – re-instate stat dispensing
- Bevacizumab inj 25 mg per ml, 4 ml and 16 ml vial (Vegzelma) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria
- Calcitriol (Calcitriol XL) cap 0.25 mcg and 0.5 mcg – amended brand name
- Dipyridamole (Pytazen SR) tab long-acting 150 mg – remove stat dispensing
- Elexacaftor with tezacaftor, ivacaftor and ivacaftor (Trikafta) tab elexacaftor 50 mg with tezacaftor 25 mg, ivacaftor 37.5 mg (56) and ivacaftor 75 mg (28) and tab elexacaftor 100 mg with tezacaftor 50 mg, ivacaftor 75 mg (56) and ivacaftor 150 mg (28), 84 OP – amended Special Authority criteria
- Insulin pump cartridge (Tandem Cartridge) cartridge 300 U, t:lock × 10, 10 OP – amended quantities on prescription
- Insulin pump reservoir 10 × 1.6 ml glass reservoir for YpsoPump, 10 OP (mylife YpsoPump Reservoir), 10 × luer lock conversion cartridges 1.8 ml for Paradigm pumps, 10 OP (ADR Cartridge 1.8) and cartridge for 7 series pump; 3.0 ml × 10, 10 OP (MiniMed 3.0 Reservoir MMT-332A) – amended quantities on prescription
- Isotretinoin (Oratane) cap 5 mg, 10 mg and 20 mg – amended Special Authority criteria
- Methylphenidate hydrochloride extended-release tab extended-release 18 mg, 27 mg, 36 mg and 54 mg (Concerta) and cap modified-release 10 mg, 20 mg, 30 mg and 40 mg (Ritalin LA) – amended Special Authority criteria
- Modafinil (Modafinil Max Health and Modavigil) tab 100 mg – amended Special Authority criteria
- Nivolumab inj 10 mg per ml, 4 ml and 10 ml vial (Opdivo) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria
- Pneumococcal (PPV23) polysaccharide vaccine (Pneumovax 23) inj 575 mcg in 0.5 ml prefilled syringe (25 mcg of each 23 pneumococcal serotype) – amended funding criteria
- Sunitinib (Sunitinib Pfizer) cap 12.5 mg, 25 mg and 50 mg – amended Special Authority criteria
- Tacrolimus (Tacrolimus Sandoz) cap 0.5 mg, 0.75 mg, 1 mg and 5 mg – amended Special Authority criteria
- Teriflunomide (Teriflunomide Sandoz) tab 14 mg – addition of brand switch fee
- Ursodeoxycholic acid (Ursosan) cap 250 mg – amended Special Authority criteria
Increased subsidy
Chemical |
Presentation |
Fully subsidised brands |
---|---|---|
Calcium folinate |
Inj 10 mg per ml, 5 ml, 10 ml and 100 ml vial Inj 1 mg for ECP |
Eurofolic Baxter |
Decreased subsidy
Chemical |
Presentation |
Fully subsidised brands |
---|---|---|
Bendamustine hydrochloride |
Inj 1 mg for ECP |
Baxter |
Diclofenac sodium |
Tab long-acting 75 mg |
Voltaren SR |
Nivolumab |
Inj 1 mg for ECP |
Baxter |